Abstract:Purpose of review: Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects approximately 1 in 2,500 individuals globally [Ashizawa et al.: Neurol Clin Pract 2018;8(6):507-20]. In patients with DM1, respiratory muscle weakness frequently evolves, leading to respiratory failure as the main cause of death in this patient population, followed by cardiac complications [de Die-Smulders et al.: Brain 1998;121(Pt 8):1557-63], [Mathieu et al.: Neurology 1999;52(8):1658-62], [Groh et al.: Muscle Nerve 2011;43(5):648-51]. This paper provides a more detailed outline on the diagnostic and management protocols, which can guide pulmonologists who may not have experience with DM1 or who are not part of a neuromuscular multidisciplinary clinic. A group of neuromuscular experts in DM1 including pulmonologists, respiratory physiotherapists and sleep specialists discussed respiratory testing and management at baseline and during follow-up visits, based on their clinical experience with patients with DM1. The details are presented in this report. Recent findings: Myotonic recruited 66 international clinicians experienced in the treatment of people living with DM1 to develop and publish consensus-based care recommendations targeting all body systems affected by this disease [Ashizawa et al.: Neurol Clin Pract. 2018;8(6):507-20]. Myotonic then worked with 12 international respiratory therapists, pulmonologists and neurologists with long-standing experience in DM respiratory care to develop consensus-based care recommendations for pulmonologists using a methodology called the Single Text Procedure. This process generated a 7-page document that provides detailed respiratory care recommendations for the management of patients living with DM1. This consensus is completely based on expert opinion and not backed up by empirical evidence due to limited clinical care data available for respiratory care management in DM patients. Nevertheless, we believe it is of relevance for professionals treating adults with myotonic dystrophy because it addresses practical issues related to respiratory management and care, which have been adapted to meet the specific issues in patients with DM1. Summary: The resulting recommendations are intended to improve respiratory care for the most vulnerable of DM1 patients and lower the risk of untoward respiratory complications and mortality by providing pulmonologist who are less experienced with DM1 with practical indications on which tests and when to perform them, adapting the general respiratory knowledge to specific issues related to this multiorgan disease.

Pitfalls in the diagnosis of complete hydatidiform mole with coexistent live fetus

ATS core curriculum 2023. Pediatric pulmonary medicine: Respiratory disorders in infants

Neuromuscular Disorders in Pediatric Respiratory Disease

Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy

Mapping of the Tuple1 gene to mouse chromosome 16A-B1.

Characteristics of associated reactions in people with hemiplegic cerebral palsy.

Respiratory Implications of Pediatric Neuromuscular Disease

Improving Access and Guideline Adherence in Pulmonary Care in Patients With Duchenne Muscular Dystrophy

Genetic therapies and respiratory outcomes in patients with neuromuscular disease

Functional-join processing

Inhibition of dopamine beta-hydroxylase by aromatic and alkyl thioureas.

Respiratory Diagnostic Tools in Neuromuscular Disease

Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1

Purification of the scrapie agent by density gradient centrifugation.

A Brief Commentary and a Preliminary Literature Search concerning the Role of Warning Signs in the Treatment and Prevention of Intimate Partners' Violence

Pediatric neuromuscular disorders: Care considerations during the COVID-19 pandemic

Sleep and sleep-related breathing disorders in patients with spinal muscular atrophy: a changing perspective from novel treatments?

[Changes in height and weight of Polish children in the last 60 years].

Age-Specific Chlamydial Infection Among Pregnant Women in the United States: Evidence for Updated Recommendations

Age-related self-stigma of people over 65 years old: adaptation of the Internalized Stigma of Mental Illness scale (ISMI) for use in age-related self-stigma (IS65+) in a Spanish sample

Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy